The move will let the chief executive retain his stock options in the event of a change in control of the company, per a new ...

On a non-GAAP basis, Tevogen reported an adjusted loss from operations of $2.5 million and $7.8 million for the three and nine months ended September 30, 2025, respectively. This represents a ...

Q3 2025 Earnings Call Transcript November 13, 2025 TriSalus Life Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.96 EPS, expectations were $-0.17. Operator: Good afternoon, and ...

Remote work can still pay big. Explore 12 entry-level jobs you can do from home that offer salaries of $50,000 or more and ...

Payscale’s Compass is a first-of-its-kind executive intelligence solution that translates compensation data into business insights. It enables HR and finance leaders to evaluate the effectiveness of ...

Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...

Inovio Pharmaceuticals (INO) reported a disappointing 3Q25 with a GAAP EPS loss of -$0.87, missing consensus by $0.45 and ...